These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 1780963)

  • 1. Valproic acid dosages necessary to maintain therapeutic concentrations in children.
    Suzuki Y; Cox S; Hayes J; Walson PD
    Ther Drug Monit; 1991 Jul; 13(4):314-7. PubMed ID: 1780963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum concentrations of rufinamide in children and adults with epilepsy: the influence of dose, age, and comedication.
    May TW; Boor R; Rambeck B; Jürgens U; Korn-Merker E; Brandt C
    Ther Drug Monit; 2011 Apr; 33(2):214-21. PubMed ID: 21383651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the factors influencing anti-epileptic drug concentrations--valproic acid.
    Ieiri I; Higuchi S; Hirata K; Yamada H; Aoyama T
    J Clin Pharm Ther; 1990 Oct; 15(5):351-63. PubMed ID: 2289937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between valproic acid dosage, plasma concentration and clearance in adult monotherapy patients with epilepsy.
    Gidal BE; Pitterle ME; Spencer NW; Maly MM
    J Clin Pharm Ther; 1995 Aug; 20(4):215-9. PubMed ID: 8557785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum concentrations of valproic acid: influence of dose and comedication.
    May T; Rambeck B
    Ther Drug Monit; 1985; 7(4):387-90. PubMed ID: 3936236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of age and concurrent medication on steady-state valproic acid serum level-dose ratios in Japanese paediatric patients.
    Yukawa E; Suzuki A; Higuchi S; Aoyama T
    J Clin Pharm Ther; 1991 Aug; 16(4):291-7. PubMed ID: 1939408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of coadministered antiepileptic drugs on serum phenobarbital concentrations in epileptic patients: quantitative analysis based on a suitable transforming factor.
    Fukuoka N; Tsukamoto T; Uno J; Kimura M; Morita S
    Biol Pharm Bull; 2004 Dec; 27(12):2000-5. PubMed ID: 15577220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.
    Dutta S; Reed RC
    J Clin Pharm Ther; 2006 Aug; 31(4):321-9. PubMed ID: 16882100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduction of steady-state valproate levels by other antiepileptic drugs.
    Sackellares JC; Sato S; Dreifuss FE; Penry JK
    Epilepsia; 1981 Aug; 22(4):437-41. PubMed ID: 6790273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic polymorphisms and valproic acid plasma concentration in children with epilepsy on valproic acid monotherapy.
    Mei S; Feng W; Zhu L; Yu Y; Yang W; Gao B; Wu X; Zhao Z; Fang F
    Seizure; 2017 Oct; 51():22-26. PubMed ID: 28763744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of age and co-medication on the concentration and efficacy of valproic acid in Chinese epilepsy children.
    Wang Y; Hu W; Li Z
    Pak J Pharm Sci; 2020 Mar; 33(2):537-542. PubMed ID: 32276895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of steady-state pharmacokinetics of valproic acid in children between monotherapy and multiple antiepileptic drug treatment.
    Chiba K; Suganuma T; Ishizaki T; Iriki T; Shirai Y; Naitoh H; Hori M
    J Pediatr; 1985 Apr; 106(4):653-8. PubMed ID: 3920375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid clearance in children with epilepsy.
    Sánchez-Alcaraz A; Quintana MB; López E; Rodríguez I
    J Clin Pharm Ther; 1998 Feb; 23(1):31-4. PubMed ID: 9756109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of valproic acid in children: I. Multiple antiepileptic drug therapy.
    Cloyd JC; Kriel RL; Fischer JH; Sawchuk RJ; Eggerth RM
    Neurology; 1983 Feb; 33(2):185-91. PubMed ID: 6401848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Influence of coadministered antiepileptic drugs on serum antiepileptic drug concentrations in epileptic patients -quantitative analysis based on suitable transforming factor].
    Fukuoka N
    Yakugaku Zasshi; 2004 Jul; 124(7):443-50. PubMed ID: 15235228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A population pharmacokinetic model of valproic acid in pediatric patients with epilepsy: a non-linear pharmacokinetic model based on protein-binding saturation.
    Ding J; Wang Y; Lin W; Wang C; Zhao L; Li X; Zhao Z; Miao L; Jiao Z
    Clin Pharmacokinet; 2015 Mar; 54(3):305-17. PubMed ID: 25388986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. No effect of co-administered antiepileptic drugs on in-vivo protein binding parameters of valproic acid in patients with epilepsy.
    Suzuki Y; Itoh H; Abe T; Nishimura F; Sato Y; Takeyama M
    J Pharm Pharmacol; 2011 Jul; 63(7):976-81. PubMed ID: 21635265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of age and co-medication on the steady-state pharmacokinetics of valproic acid in Tunisian patients with epilepsy.
    Ben Mahmoud L; Hakim A; Ghozzi H; Atheymen R; Sahnoun Z; Zeghal K
    Rev Neurol (Paris); 2017 Mar; 173(3):159-163. PubMed ID: 28320517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unbound valproate fraction in plasma and subcutaneous microdialysate in steady state and after a single dose in humans.
    Lindberger M; Tomson T; Ståhle L
    Ther Drug Monit; 2003 Jun; 25(3):378-83. PubMed ID: 12766568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Valproic acid pharmacokinetics in children: III. Very high dosage requirements.
    Kriel RL; Fischer JH; Cloyd JC; Green KH; Fraser GL
    Pediatr Neurol; 1986; 2(4):202-8. PubMed ID: 3150281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.